FY2025 · period end Dec '25 · from the 10-K filed Feb 11, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY23Jan '23 | FY22Jan '22 |
|---|---|---|---|---|---|
| Revenue | $94.19B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0000200406-26-000089 | Apr 23, 2026 | Apr 28, 2026 | Apr 27, 2026 21:33 UTC | EDGAR |
| 10-Q | 0000200406-26-000087 | Mar 29, 2026 | Apr 22, 2026 | Apr 22, 2026 20:02 UTC | EDGAR |
| 8-K | 0000200406-26-000076 | Apr 14, 2026 | Apr 14, 2026 | Apr 14, 2026 11:35 UTC | EDGAR |
| 10-K | 0000200406-26-000016 | Dec 28, 2025 | Feb 11, 2026 | Feb 11, 2026 21:06 UTC | EDGAR |
| 8-K | 0000200406-26-000002 | Jan 21, 2026 | Jan 21, 2026 | Jan 21, 2026 12:46 UTC | EDGAR |
| 10-Q | 0000200406-25-000209 | Sep 28, 2025 | Oct 22, 2025 | Oct 22, 2025 20:04 UTC | EDGAR |
| 8-K | 0000200406-25-000201 | Oct 14, 2025 | Oct 14, 2025 | Oct 14, 2025 11:22 UTC | EDGAR |
| 8-K | 0000200406-25-000190 | Sep 8, 2025 | Sep 9, 2025 | Sep 8, 2025 23:55 UTC | EDGAR |
Direct links to SEC EDGAR. JNJ has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·Q1 2023
Major restatementwas-$737M
Revised down in a 10-Q.
Income (Loss) from Continuing Operations before Income Taxes, Domestic·FY 2022
Major restatementwas$6.1B
Revised down in a 10-K.
Net Cash Provided by (Used in) Operating Activities·Q1 2016
Major restatementwas$1.8B
Revised up in a 10-Q. Any P/OCF built on the original was 19.5% too high.
Revenue from Contract with Customer, Excluding Assessed Tax·FY 2022
Major restatementwas$93.8B
Revised down in a 10-K. Any P/S built on the original was 19.1% too low.
Revenue from Contract with Customer, Excluding Assessed Tax·Q3 2022
Major restatementwas$23.8B
Revised down in a 10-K. Any P/S built on the original was 19.0% too low.
Revenue from Contract with Customer, Excluding Assessed Tax·Q2 2022
Major restatementwas$24B
Revised down in a 10-K. Any P/S built on the original was 18.8% too low.
JNJ is not the only one.
See every restatement we've found across the market — or get an alert the next time JNJ revises a number.
Restatements are detected by comparing every vintage of a fact across all of JOHNSON & JOHNSON's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows JNJ's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling JOHNSON & JOHNSON — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on JNJ yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on JNJ and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $85.16B |
| $79.99B |
| $78.74B |
| Gross Profit | $63.94B | $61.35B | $58.61B | $55.39B | $55.34B |
|---|
| Operating Income | — | — | — | — | — |
|---|
| Net Income | $26.80B | $14.07B | $35.15B | $17.94B | $20.88B |
|---|
| EPS (Diluted) | $11.03 | $5.79 | $13.72 | $6.73 | $7.81 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY23Jan '23 | FY22Jan '22 |
|---|---|---|---|---|---|
| Total Assets | $199.21B | $180.10B | $167.56B | $187.38B | $182.02B |
| Total Liabilities | $117.67B | $108.61B | $98.78B | $110.57B | $108.00B |
| Stockholders' Equity | $81.54B | $71.49B | $68.77B | $76.80B | $74.02B |
| Cash & Equivalents | $19.71B | $24.11B | $21.86B | $14.13B | $14.49B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY23Jan '23 | FY22Jan '22 |
|---|---|---|---|---|---|
| Operating Cash Flow | $24.53B | $24.27B | $22.79B | $21.19B | $23.41B |
| Capital Expenditures | $4.83B | $4.42B | $4.54B | $4.01B | $3.65B |
| Free Cash Flow | $19.70B | $19.84B | $18.25B | $17.18B | $19.76B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY23Jan '23 | FY22Jan '22 |
|---|---|---|---|---|---|
| Gross Margin | 67.9% | 69.1% | 68.8% | 69.3% | 70.3% |
| Operating Margin | 0.2% | 0.2% | 0.1% | 0.1% | 0.1% |
| Net Margin | 0.3% | 0.2% | 0.2% | 0.2% | 0.3% |
| Return on Equity | 35.0% | 20.1% | 23.8% | 23.8% | 30.4% |
| Return on Assets | 14.1% | 8.1% | 9.7% | 9.7% | 11.7% |
| Debt / Equity | 0.64× | 0.56× | 0.56× | 0.56× | 0.51× |
